Drug Binding to DNA⋅RNA Hybrid Structures
- 6 November 2009
- book chapter
- Published by Springer Nature
- Vol. 613, 55-70
Abstract
DNA·RNA hybrid duplexes are functionally important structures in gene expression that are underutilized as potential drug targets. Several tools are described here for the discovery and characterization of small molecules capable of the selective recognition of DNA·RNA hybrid structures. Competition dialysis and thermal denaturation of mixtures of polynucleotide structures can be used to identify small molecules that bind selectively to DNA·RNA hybrids. An assay that measures small molecule inhibition of RNase H can be used to measure a functional response to these ligands.Keywords
This publication has 39 references indexed in Scilit:
- Regulation of Telomerase Activity by the Thermodynamic Stability of a DNA⋅RNA HybridAngewandte Chemie International Edition, 2008
- Molecular recognition of a DNA:RNA hybrid: Sub-nanomolar binding by a neomycin–methidium conjugateBioorganic & Medicinal Chemistry Letters, 2008
- Use of competition dialysis in the discovery of G-quadruplex selective ligandsMethods, 2007
- Competition dialysis: A method for the study of structural selective nucleic acid bindingMethods, 2007
- Discovery of the Hybrid Helix and the First DNA-RNA HybridizationJournal of Biological Chemistry, 2006
- Aminoglycoside Complexation with a DNA·RNA Hybrid Duplex: The Thermodynamics of Recognition and Inhibition of RNA Processing EnzymesJournal of the American Chemical Society, 2003
- A Competition Dialysis Assay for the Study of Structure‐Selective Ligand Binding to Nucleic AcidsCurrent Protocols in Nucleic Acid Chemistry, 2002
- Comparison of the Thermodynamic Stabilities and Solution Conformations of DNA·RNA Hybrids Containing Purine-Rich and Pyrimidine-Rich Strands with DNA and RNA DuplexesBiochemistry, 1996
- Bromination stabilizes poly(dG-dC) in the Z-DNA form under low-salt conditionsBiochemistry, 1984
- Calculation of melting curves for DNABiopolymers, 1968